top of page
Search


Encounter Resources starts RC drilling at Haddon copper prospect (Paterson Province, WA)
Encounter Resources Limited (ASX: ENR) has kicked off a 6-hole RC program at the Haddon copper prospect (formerly BM5) within its 100%-owned Yeneena Copper Project in the Paterson Province, ~50 km SE of Nifty, WA (Figure 1). The target sits on a major fault with coincident EM resistive response and prior aircore results that finished in gossanous, multi-element anomalism—an undercover setting analogous in style to nearby sediment-hosted copper systems and magmatic Cu-Au depos

Noel Ong
Oct 29, 20256 min read


Orange Minerals – Lennon’s Find Project: Rock Chips to 2,948 g/t Ag ahead of first deep IP test - Some Silver Signs or Is there Something More Interesting To Come.
Orange Minerals NL (ASX: OMX) has released new surface sampling results from the Lennon’s Find polymetallic project in the Pilbara, with rock chips returning standout precious and base-metal grades along a 4.5 km mineralised corridor (Figure 1). The company is moving to a single 650m diamond hole in early November to directly test a pronounced induced polarisation (IP) anomaly interpreted as a potential feeder to the known zinc-lead-silver system.

Noel Ong
Oct 28, 20256 min read


WYX targets high-grade gallium in WA: exploration planning underway, new licence granted. A Gallium Story with Substance - #SamsoDYOR.
Western Yilgarn Limited (ASX: WYX) has kicked off ground-exploration planning over two gallium targets in Western Australia—Ida Holmes Junction (Figure 1) and New Norcia—building on very high-grade rock chips and historical aircore intercepts. The Company also confirms a newly granted exploration licence at New Norcia and outlines imminent on-ground reconnaissance, including helicopter follow-up over Ida Holmes Junction.

Noel Ong
Oct 27, 20256 min read


Andromeda Metals—HPA pilot program moves into continuous production and customer sampling.
Andromeda Metals Limited (ASX: ADN) has advanced its High-Purity Alumina (HPA) strategy, initiating pilot-scale testwork to move its proprietary flowsheet from batch trials into continuous production— using refined kaolin feedstock from the Great White Project (Figure 1)—a key step flagged in the recent HPA Scoping Study.

Noel Ong
Oct 24, 20255 min read


Rumble Resources — Major diamond drilling program underway at Western Queen gold–tungsten project.
Rumble Resources Limited (ASX: RTR) has kicked off a ~20,000 m diamond program at Western Queen (Figure 1), with two DDH1 rigs chasing high-grade down-plunge gold beneath the South and Central pits while advancing sub-parallel tungsten lodes. The work targets growth/upgrade of the 370 koz @ 3.1 g/t Au MRE and builds on the 13.2 kt WO₃ tungsten MRE, supported by geotech and metallurgy (+93% historical Au recovery).

Noel Ong
Oct 23, 20256 min read


DevEx Resources—Kilometre-scale pathfinder anomalies emerge at Murphy West, NT - A Developing Uranium Story.
DevEx Resources Limited (ASX: DEV) has put a clear frame around the Murphy West story: first-pass soils are lighting up kilometre-scale, multi-element pathfinder halos across radiometric and structural targets on the southern margin of the McArthur Basin (Figure 1), echoing the Junnagunna orientation model where Pb–Cu–Be mark buried uranium.

Noel Ong
Oct 22, 20255 min read


OD6 kicks off Phase 2 drilling at Gulf Creek Copper (NSW)
OD6 Metals Limited (ASX: OD6) commenced Phase 2 drilling at the 100%-owned Gulf Creek Copper Project (NSW), advancing the first modern program over a historically high-grade VMS system. The campaign targets along-strike repeats of the Gulf Creek mine stratigraphy where magnetics, jaspilite exhalites, and surface pathfinders coincide (Figure 1).

Noel Ong
Oct 22, 20256 min read


Race Oncology: Bisantrene’s Primary MOA Identified as G-Quadruplex (G4) Binding - Anti-Cancer Narrative
Race Oncology Limited (ASX: RAC) has reported a pivotal mechanistic discovery: its lead molecule (E,E)-bisantrene (RCDS1) primarily exerts anticancer activity by binding and stabilising G-quadruplex (G4) structures in DNA and RNA—not via an anthracycline-like pathway. The company positions this as a step-change for clinical strategy, biomarker development, and partnering.

Noel Ong
Oct 21, 20256 min read


Echo IQ (ASX: EIQ): Strong Operational Momentum & Regulatory Milestones. Recent Setback May Be A Discount Opportunity for Investors - Diagnosing Heart Disease.
Echo IQ Limited (ASX: EIQ) has delivered a concise update showing rising clinical usage for EchoSolv™ AS, clear progress on EchoSolv™ HF’s FDA pathway, and expanding commercial channels in the US and Europe. The near-term catalysts are anchored in actual hospital integrations, validation work nearing completion, and newly appointed US key opinion leaders guiding adoption.

Noel Ong
Oct 20, 20258 min read


The Calmer Co. International Limited Q1 FY26 - Record $2.4m Quarterly Sales (+26%) - The Kava Revolution.
The Calmer Co. International Limited (ASX: CCO) has reported the strongest quarter in its history with Q1 FY26 sales of $2.4 million, up 26% on Q4 FY25 ($1.9m). Growth was broad-based across Australian retail, the USA, and B2B channels, with additional funding commitments to support inventory and expansion.

Noel Ong
Oct 17, 20256 min read
bottom of page
